IP Library Assignment 014342/0813
Patent Assignment
Reel/Frame 014342/0813

Assignment of Assignor's Interest

Recorded: 2003-08-01 Pages: 4
Assignors
HOVEY, DOUGLAS
Executed: 2003-04-29
PRUITT, JOHN
Executed: 2003-05-01
RYDE, TUULA
Executed: 2003-04-22
Assignee
ELAN PHARMA INTERNATIONAL LTD.
3500 HORIZON DRIVE, KING OF PRUSSIA, PENNSYLVANIA, 19406
Covered Property (1)
Nanoparticulate Megestrol Formulations
Patent: 7,101,576 →
Application: 10/412,669 →
Publication: US 2003/0219490
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Patent Security Agreement (First Lien) Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0186 →
Patent Security Agreement (Second Lien) Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0245 →
Asset Transfer Agreement Oct 25, 2011
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 027118/0091 →
Change of Name Oct 26, 2011
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 027120/0405 →
Release by Secured Party (Second Lien) Oct 12, 2012
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
Reel/Frame 029116/0379 →
Release of Patent Security Agreement (First Lien) Dec 24, 2024
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 069771/0548 →